Bhubaneswar: The Indian Council of Medical Research (ICMR) has nominated Odisha-born physician Professor (Dr) Digambar Behera as a member of the clinical research group under the National Task Force for COVID-19.
The six-member medical group will be led by AIIMS New Delhi director Randeep Guleria.
Behera, who is a professor of pulmonary medicine at PGIMER Chandigarh, said the group will be involved in quick information gathering on COVID-19 and formulate a treatment strategy for India.
“We will discuss how the disease is behaving in different ways in different countries and what is causing death. We will then evolve the clinical practice needed for India,” Behera was quoted as saying by the Times of India.
“There will also be more focused approach towards hydroxychlorouine, which many consider as a potential drug for COVID-19,” he added.
A Padma Shri awardee, Behera was born in Cuttack district in 1953. He is an alumnus of SCB Medical College and Hospital and is known as a pioneer of lung cancer chemotherapy in the country.
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
Balasore: With the festival of Maha Shivratri fast approaching, hectic preparations are underway at the… Read More
New Delhi: In a recent social media post, actress Kangana Ranaut sparked controversy by defending… Read More
This website uses cookies.